149 related articles for article (PubMed ID: 20924040)
1. Applying toxicological risk assessment principles to constituents of smokeless tobacco products: implications for product regulation.
Ayo-Yusuf OA; Connolly GN
Tob Control; 2011 Jan; 20(1):53-7. PubMed ID: 20924040
[TBL] [Abstract][Full Text] [Related]
2. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.
Song MA; Marian C; Brasky TM; Reisinger S; Djordjevic M; Shields PG
Toxicol Lett; 2016 Mar; 245():68-77. PubMed ID: 26802282
[TBL] [Abstract][Full Text] [Related]
3. Chemical and toxicological characterization of commercial smokeless tobacco products available on the Canadian market.
Rickert WS; Joza PJ; Trivedi AH; Momin RA; Wagstaff WG; Lauterbach JH
Regul Toxicol Pharmacol; 2009 Mar; 53(2):121-33. PubMed ID: 19135498
[TBL] [Abstract][Full Text] [Related]
4. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs).
Back S; Masser AE; Rutqvist LE; Lindholm J
BMC Chem; 2023 Mar; 17(1):9. PubMed ID: 36869349
[TBL] [Abstract][Full Text] [Related]
5. Monitoring tobacco-specific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: findings from Round 1 of the New Product Watch.
Stepanov I; Biener L; Knezevich A; Nyman AL; Bliss R; Jensen J; Hecht SS; Hatsukami DK
Nicotine Tob Res; 2012 Mar; 14(3):274-81. PubMed ID: 22039075
[TBL] [Abstract][Full Text] [Related]
6. Bacterial Populations Associated with Smokeless Tobacco Products.
Han J; Sanad YM; Deck J; Sutherland JB; Li Z; Walters MJ; Duran N; Holman MR; Foley SL
Appl Environ Microbiol; 2016 Oct; 82(20):6273-6283. PubMed ID: 27565615
[TBL] [Abstract][Full Text] [Related]
7. Assessment of concentration and toxicological (Cancer) risk of lead, cadmium and chromium in tobacco products commonly available in Bangladesh.
Hossain MT; Hassi U; Imamul Huq SM
Toxicol Rep; 2018; 5():897-902. PubMed ID: 30191134
[TBL] [Abstract][Full Text] [Related]
8. In vitro permeation of nicotine and tobacco specific nitrosamines from smokeless tobacco product extracts in a 3D buccal tissue model.
Keyser BM; Flockton H; Weidman RA; Payne R; Rowe J; Jordan KG
Toxicol Lett; 2024 Feb; 392():36-45. PubMed ID: 38142871
[TBL] [Abstract][Full Text] [Related]
9. Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.
Stepanov I; Biener L; Yershova K; Nyman AL; Bliss R; Parascandola M; Hatsukami DK
Nicotine Tob Res; 2014 Aug; 16(8):1070-8. PubMed ID: 24604020
[TBL] [Abstract][Full Text] [Related]
10. The composition of contemporary American and Swedish smokeless tobacco products.
McAdam KG; Kimpton H; Faizi A; Porter A; Rodu B
BMC Chem; 2019 Dec; 13(1):31. PubMed ID: 31384779
[TBL] [Abstract][Full Text] [Related]
11. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
[TBL] [Abstract][Full Text] [Related]
12. The chemical composition of smokeless tobacco: a survey of products sold in the United States in 2006 and 2007.
Borgerding MF; Bodnar JA; Curtin GM; Swauger JE
Regul Toxicol Pharmacol; 2012 Dec; 64(3):367-87. PubMed ID: 23000415
[TBL] [Abstract][Full Text] [Related]
13. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
Richter P; Hodge K; Stanfill S; Zhang L; Watson C
Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
[TBL] [Abstract][Full Text] [Related]
15. A qualitative and quantitative risk assessment of snuff dipping.
Nilsson R
Regul Toxicol Pharmacol; 1998 Aug; 28(1):1-16. PubMed ID: 9784428
[TBL] [Abstract][Full Text] [Related]
16. Chemical composition and carcinogenicity of smokeless tobacco.
Hoffmann D; Djordjevic MV
Adv Dent Res; 1997 Sep; 11(3):322-9. PubMed ID: 9524432
[TBL] [Abstract][Full Text] [Related]
17. Smokeless Tobacco Products (STPs) Harbour Bacterial Populations with Potential for Oral Carcinogenicity.
Monika S; Dineshkumar T; Priyadharini S; Niveditha T; Sk P; Rajkumar K
Asian Pac J Cancer Prev; 2020 Mar; 21(3):815-824. PubMed ID: 32212812
[TBL] [Abstract][Full Text] [Related]
18. Assessment of potential toxicity of a smokeless tobacco product (naswar) available on the Pakistani market.
Zakiullah ; Saeed M; Muhammad N; Khan SA; Gul F; Khuda F; Humayun M; Khan H
Tob Control; 2012 Jul; 21(4):396-401. PubMed ID: 21642445
[TBL] [Abstract][Full Text] [Related]
19. The acrylamide content of smokeless tobacco products.
McAdam K; Kimpton H; Vas C; Rushforth D; Porter A; Rodu B
Chem Cent J; 2015; 9():56. PubMed ID: 26473006
[TBL] [Abstract][Full Text] [Related]
20. High-Intensity Sweeteners in Alternative Tobacco Products.
Miao S; Beach ES; Sommer TJ; Zimmerman JB; Jordt SE
Nicotine Tob Res; 2016 Nov; 18(11):2169-2173. PubMed ID: 27217475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
